关注
Jooyoung Park
Jooyoung Park
Sana Biotechnology
在 wustl.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
De novo design of modular and tunable protein biosensors
A Quijano-Rubio, HW Yeh, J Park, H Lee, RA Langan, SE Boyken, ...
Nature 591 (7850), 482-487, 2021
1852021
Plasticity, dynamics, and inhibition of emerging tetracycline resistance enzymes
NHT Jooyoung Park, Andrew J Gasparrini, Margaret R Reck, Chanez T Symister ...
Nature Chemical Biology, 2017
1142017
A sugar phosphatase regulates the methylerythritol phosphate (MEP) pathway in malaria parasites
AM Guggisberg, J Park, RL Edwards, ML Kelly, DM Hodge, NH Tolia, ...
Nature communications 5, 2014
862014
Molecular Mechanism of Action of Antimalarial Benzoisothiazolones: Species-Selective Inhibitors of the Plasmodium spp. MEP Pathway enzyme, IspD
KE Price, CM Armstrong, LS Imlay, DM Hodge, C Pidathala, NJ Roberts, ...
Scientific reports 6 (1), 36777, 2016
262016
Cap-domain closure enables diverse substrate recognition by the C2-type haloacid dehalogenase-like sugar phosphatase Plasmodium falciparum HAD1
J Park, AM Guggisberg, AR Odom, NH Tolia
Acta Crystallographica Section D: Biological Crystallography 71 (9), 1824-1834, 2015
232015
De novo design of a homo-trimeric amantadine-binding protein
J Park, B Selvaraj, AC McShan, SE Boyken, KY Wei, G Oberdorfer, ...
Elife 8, e47839, 2019
192019
De novo design of modular and tunable allosteric biosensors
A Quijano-Rubio, HW Yeh, J Park, H Lee, RA Langan, SE Boyken, ...
bioRxiv, 2020.07. 18.206946, 2020
72020
Amantadine binding protein
J Park, S Boyken, WEI Kathy, G Oberdorfer, D Baker
US Patent App. 17/603,080, 2022
2022
Modular and generalizable biosensor platform based on de novo designed protein switches
AQ RUBIO, J Park, HW Yeh, D Baker, CAO Longxing, B Coventry, ...
2021
Inhibition and diagnostics of emerging tetracycline resistance enzymes
N Tolia, G Dantas, T Wencewicz, J Park, A Gasparrini, K Forsberg, ...
US Patent 10,273,468, 2019
2019
系统目前无法执行此操作,请稍后再试。
文章 1–10